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E-mail address: marco.sandri@unipd.itMuscle mass represents 40–50% of the human body and, in mammals, is one of the most important
sites for the control of metabolism. Moreover, during catabolic conditions, muscle proteins are
mobilized to sustain gluconeogenesis in the liver and to provide alternative energy substrates for
organs. However, excessive protein degradation in the skeletal muscle is detrimental for the econ-
omy of the body and it can lead to death. The ubiquitin-proteasome and autophagy-lysosome sys-
tems are the major proteolytic pathways of the cell and are coordinately activated in atrophying
muscles. However, the role and regulation of the autophagic pathway in skeletal muscle is still lar-
gely unknown. This review will focus on autophagy and discuss its beneﬁcial or detrimental role for
the maintenance of muscle mass.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Skeletal muscles are the body’s agent of motion. In order to
allow movement, the organization of muscle cells is highly struc-
tured so as to generate and sustain mechanical tension. The cytosol
of myoﬁbers is packed with contractile proteins that are assembled
into repetitive structures, the basal unit of which is constituted by
the sarcomere. Filaments of myosins are at the center of the
sarcomere while ﬁlaments of actins are at the periphery. Several
sarcomeres, arranged in register and surrounded by sarcoplasmic
reticulum, form myoﬁbrils. Various organelles such as mitochon-
dria, for ATP generation, and sarcoplasmic reticulum, for calcium
release are embedded among the myoﬁbrils. This ordered assem-
bly of contractile proteins and organelles differs from the cytosolic
organization of the other cells of our body where mitochondria,
endoplasmic reticulum and proteins move freely within the cyto-
sol. Moreover, the myoﬁber is an enormous cell that can measure
several centimeters in length and can contain hundreds of nuclei.
It is therefore particularly difﬁcult to visualize local as well as
subtle but diffuse changes of mitochondrial and endo/sarcoplasmic
reticulum networks as well as the dynamics of endocytic/exocyticchemical Societies. Published by E
iversity of Padova, Dulbecco
dicine (VIMM), Viale Orus 2,vesicles in such rigid and long structures. Several changes occur
during catabolic conditions: proteins are mobilized, mitochondrial
and sarcoplasmic networks are remodeled and myonuclei are lost.
In addition, the daily contractions can mechanically and metabol-
ically damage/alter muscle proteins and organelles. For example,
physical exercise requires energy whose production in mitochon-
dria can also generate reactive oxygen species (ROS) that can have
deleterious effects on many cellular components. Muscle cells
therefore require an efﬁcient system for removing and eliminating
unfolded and toxic proteins as well as abnormal and dysfunctional
organelles. The autophagy system is responsible for this action,
generating double membrane vesicles that engulf portion of cyto-
plasm, organelles, glycogen and protein aggregates [1,2]. Auto-
phagosomes are then delivered to lysosomes for degradation of
their contents. Despite this important function, the role of autoph-
agy in the control of muscle mass has only recently begun to be
investigated.
2. Autophagy and muscle loss
Loss of muscle mass occurs in many conditions ranging from
denervation, inactivity, microgravity, fasting to a multitude of sys-
temic diseases such as cancer, sepsis, AIDS, diabetes, cardiac and
renal failure [3]. In all of these catabolic conditions protein break-
down is enhanced and exceeds protein synthesis resulting in
myoﬁber atrophy [4]. The activation of the major proteolyticlsevier B.V. All rights reserved.
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gene expression in different models of muscle atrophy lead to
the identiﬁcation of a subset of genes that are commonly up- or
down-regulated in atrophying muscle [5–8]. These common genes
are thought to regulate the loss of muscle components and were
thus designated atrophy-related genes or atrogenes [4,9]. Among
these genes there are several belonging to the autophagy-lyso-
some system. Importantly, two autophagy genes, LC3 and Gaba-
rap, are among the upregulated atrogenes which encode for
proteins that are degraded when autophagosomes fuse with lyso-
somes [10–12]. Together, these data strongly suggest that auto-
phagic ﬂux is increased during atrophy and that this increase
requires a transcriptional regulation to replenish components that
are lost. Indeed, previous evidence has shown that lysosomal deg-
radation contributes to protein breakdown in denervated muscle
[13,14]. However, advances in the ﬁeld were particularly slow
perhaps owing to the initial difﬁculties of autophagosome detec-
tion within the complex structure of the myoﬁber. Development
of biochemical and imaging tools to follow autophagosome for-
mation greatly improved the characterisation of autophagy in
atrophying muscles [15]. Mizushima et al. generated transgenic
mice expressing LC3 fused with GFP [16]. LC3 is the mammalian
homolog of the yeast Atg8 gene and is critical for membrane com-
mitment and growth [17]. Activation of autophagy can be now
easily visualized by the appearance of bright GFP-positive spots
within myoﬁbrils and beneath the plasma membrane of myoﬁ-
bers. Morphological analyses demonstrate the activation of the
autophagy system during fasting in skeletal muscle. This animal
model is also extremely useful for comparing the size of auto-
phagosomes in different tissues under basal and fasted conditions.
Interestingly, fasted skeletal muscle shows the smallest vesicles
when compared to autophagosomes of liver, heart and pancreatic
acinar cells [16]. Thus, the small size of autophagosomes could be
another important aspect that, in the past, had limited the detec-
tion of autophagosomes in muscle. By using these tools we have
only recently begun to unravel the contribution of autophagy to
muscle loss. For example it is now known that myoﬁber atrophy
induced in vivo by overexpression of constitutively active FoxO3
requires autophagy. Knocking down the critical gene LC3 by RNAi
partially prevents FoxO3-mediated muscle loss [10]. Other genetic
models have also conﬁrmed the role of autophagy during muscle
atrophy. Oxidative stress, inducedby expression ofmutant SOD1G93A
speciﬁcally in skeletal muscle, causes muscle atrophy and weak-
ness mainly via autophagy activation. The reduction of autopha-
gic ﬂux by expressing shRNAs against LC3 spares muscle mass
in SOD1G93A transgenic mice [18]. However, since the preserva-
tion of muscle mass was studied by morphological observations,
we do not know whether this protection is also functional and
therefore, beneﬁcial for preserving muscle force. This aspect
would be important to address in the next years for the develop-
ment of appropriate therapeutic approaches against weakness. In-
creased oxidative stress has also been reported to occur during
denervation and hindlimb suspension. During these disuse condi-
tions neuronal NOS (nNOS) moves from the sarcolemma, where it
is bound to the dystrophin-glycoprotein complex, to the cytosol.
Free cytosolic nNOS induces oxidative stress and enhances
FoxO3-mediated transcription of the atrophy-related ubiquitin li-
gases, atrogin 1 and MuRF1, causing muscle loss [19]. A similar
mechanism has been recently described in another model of mus-
cle atrophy. When DHPR, a L-type Ca2+ channel, is reduced in
skeletal muscles of adult animals by RNAi, it also triggers atrophy
via nNOS relocalization and FoxO3 activation. However, in this
genetic model of muscle atrophy, the genes that are upregulated
by FoxO3 are the autophagy genes LC3, VPS34, Bnip3 and the
lysosomal enzyme cathepsin L. Morphological studies of LC3
immunolocalization and ultrastructural observations by electronmicroscopy conﬁrm the induction of autophagosomes when
DHPR is reduced [20].
Recent data suggest that autophagy may also contribute to sar-
copenia, the excessive loss of muscle mass that occurs in the el-
derly [21]. During ageing there is also a progressive deterioration
of mitochondrial function and activation of autophagy. Forced
expression of PGC1a, the master gene of mitochondrial biogenesis,
in skeletal muscles of old mice ameliorates loss of muscle mass and
prevents the age-related increase of autophagy [22]. Thus, autoph-
agy activation has been reported in acute conditions of muscle loss
as well as in chronic and long-lasting situations of muscle debilita-
tion and weakness.
Interestingly, recent ﬁndings suggest that autophagy activation
might be critical not only for protein breakdown and muscle atro-
phy but also for myoﬁber survival. In fact mutations that inactivate
Jumpy, a phosphatase that counteracts the action of VPS34 for
autophagosome formation and reduces autophagic ﬂux, is associ-
ated with centronuclear myopathy [23]. Therefore unbalanced
autophagy might be the pathogenic mechanism that causes posi-
tional alteration of myonuclei and, consequently, triggers myoﬁber
degeneration. Together, these ﬁndings strongly suggest that exces-
sive autophagy, similar to the ubiquitin-proteasome system, is det-
rimental to muscle mass.3. Autophagy and muscle mass maintenance
Autophagosomes have been found in almost every myopathy
and dystrophy studied so far and are characteristic of a group of
muscle disorders named Autophagic Vacuolar Myopathies (AVM)
[24]. However, it is unclear whether autophagy is detrimental
and part of the mechanisms that induce muscle degeneration or
whether it is a compensatory mechanism for cell survival. The fea-
tures of protein aggregation, abnormal mitochondria and disten-
sion of endo/sarcoplasmic reticulum that are typical of many
acquired and genetic muscle diseases suggest an impairment, more
than an exacerbation, of autophagic ﬂux. For instance, protein
aggregates that are positive for ubiquitin and p62/SQSTM1 pro-
teins have been recently described in muscle of patients affected
by sporadic Inclusion Body Myositis as well as in different tissue-
speciﬁc autophagy knockout mice [25–27]. To clarify the role of ba-
sal autophagy we have generated two conditional knockout mice
for the critical Atg7 gene to block autophagy speciﬁcally in skeletal
muscle [28]. The expectation was to preserve muscle mass and
eventually to gain more contractile proteins and to improve mus-
cle strength. Surprisingly, suppression of autophagy is not beneﬁ-
cial and instead triggers atrophy, weakness and several features
of myopathy. A similar atrophic phenotype has also been observed
in muscle-speciﬁc Atg5 knockout mice, another genetic model to
block autophagy [29]. Deletion of Atg7 gene causes accumulation
of protein aggregates, appearance of abnormal mitochondria and
of concentric membranous structures that assemble between the
myoﬁbrils or just beneath the sarcolemma, induction of oxidative
stress and activation of Unfolded Protein Response. Together, these
pathological conditions lead to myoﬁber degeneration [28] (Fig. 1).
Another interesting aspect is the accumulation of polyubiquitinat-
ed proteins in detergent soluble and insoluble fractions of autoph-
agy-null muscles. This ﬁnding has been reported in other tissue-
speciﬁc autophagy knockout mice which also show an increase of
polyubiquitinated proteins and accumulation of concentric mem-
branous structures [26,27,30,31]. These observations, together
with the evidence that proteasome activity is not seriously im-
paired in Atg7 null muscles, suggest that some ubiquitinated pro-
teins are speciﬁcally targeted to lysosomal degradation via
autophagy. We actually do not know which signals establish
whether polyubiquitinated proteins are degraded via proteasome
Fig. 1. FoxO transcription factors control the ubiquitin-proteasome and autophagy-lysosome systems. In atrophying muscles the ubiquitin-proteasome system control the
half life of sarcomeric proteins. Inhibition of proteasomal-dependent degradation has been described to reduce muscle atrophy. Instead during physiological and catabolic
conditions autophagosomes remove damaged mitochondria, unfolded proteins that are prone to aggregate, control the quality of the folding process in the endoplasmic
reticulum (ER) and affect DNA stability. Impairing autophagy system causes accumulation of abnormal organelles and toxic proteins that leads to myoﬁber degeneration. The
protein substrates of autophagy are poorly understood as well as the mechanisms of delivering autophagosomes to lysosomes. Inactivation of the proteins involved in the
regulation of these steps causes different myopathies. In red are actions and genes whose inactivation is associated to different genetic and acquired myopathies. Dotted lines
depict actions whose molecular mechanisms and role in adult skeletal muscle have yet to be completely deﬁned.
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Neu2 as a speciﬁc substrate of the autophagy-lysosome system
in atrophying myotubes [32]. It is unclear whether decreased
Neu2 protein results in non-speciﬁc engulﬁng of portions of the
cytosol or whether speciﬁc post-translational modiﬁcations such
as ubiquitination selectively brings Neu2 to autophagosomes. In
fact, it is now clear that ubiquitinated proteins are delivered to
autophagosomes via p62/SQSTM1 and NBR1 proteins that bind
the polyubiquitin chains and LC3 [33–37]. Interestingly, the action
and the ubiquitination of co-chaperones has been reported as an
alternative pathway for autophagosome-dependent protein degra-
dation in skeletal muscles. Filamin is a protein that undergoes
unfolding and refolding cycles during muscle contraction and
therefore is prone to irreversible damage. Alterations of ﬁlamin
structure trigger the binding of the co-chaperone BAG3, which car-
ries the complex constituted by the chaperones Hsc70, HspB8 and
the ubiquitin ligase CHIP. CHIP ubiquitinates BAG3 and ﬁlamin
which are recognised and delivered to the autophagy system by
p62/SQSTM1 protein [38] (Fig. 1). A mutation of BAG3 that inacti-
vates ﬁlamin removal causes a severe myopathy with Z-disk disin-
tegration [38,39]. The process of delivering autophagosomes to
lysosomes is another important step in muscle protein degrada-
tion. Recent evidence underlines an unexpected role of valosin-
containing protein (VCP) in autophagosome maturation [40].
VCP/p97 is implicated in multiple processes, including cell cycle,
Golgi biogenesis, nuclear envelope formation and the ubiquitin-
proteasome system. Mutations of VCP/p97 gene cause inclusion
body myopathy (IBM), Paget disease of the bone and frontotempo-
ral dementia (IBMPFD). Interestingly, knocking down VCP/p97 or
expressing the mutant form of VCP/P97 results in accumulation
of autophagosomes that fail to fuse with lysosomes [40] (Fig. 1).
The accumulation of non-digested autophagosomes forms the
morphological structure called rimmed vacuoles and induces theformation of p62 positive protein aggregates. However, the mech-
anism by which VCP/p97 regulates autophagy is still unknown.
Understanding which proteins are the substrate of autophagy
and the mechanisms of their recognition and delivery to auto-
phagosomes are intriguing questions which will hopefully gain
attention in the near future.
Recent ﬁndings suggest that autophagy is critical for nuclear
stability (Fig. 1). Nuclear envelopathies are genetic disorders
caused by mutations in the emerin and Lamin A genes that encode
for structural proteins of the nucleus. These diseases are character-
ised by an increased nuclear fragility especially after mechanical
stresses. Importantly, skeletal and cardiac muscles are the tissues
that are most affected by these genetic defects. Giant autophago-
somes containing nuclear components including chromatin have
been found in emerin and lamin A deﬁcient cells. Importantly, inhi-
bition of autophagy led to accumulation of nuclear abnormalities
and reduced cell viability [41]. An interest aspect that suggests a
general involvement of autophagy in nuclear remodeling is the
ﬁnding that similar giant autophagosomes are also present, albeit
rarely, in wild type cells. Therefore, these data suggest that ‘‘nucle-
ophagy” may be an important mechanism for maintenance of nu-
clear stability in mammals. How exactly portions of nuclei are
removed without affecting the number of chromosomes, genes
and therefore cell viability is another crucial point that must be
clariﬁed in the near future.4. Autophagy regulation in skeletal muscle
Autophagy in skeletal muscle is peculiar when compared to
other important metabolic tissues such as the liver and pancreas.
During fasting most tissues show a transient activation of autoph-
agy that only lasts a few hours. In contrast, skeletal muscle shows a
Fig. 2. Scheme that represents positive and negative regulators of autophagy in skeletal muscle. Dotted lines depict actions whose molecular mechanisms and role in adult
skeletal muscle have yet to be completely deﬁned.
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[16]. Such prolonged autophagic induction requires transcriptional
control in order to replenish LC3 and Gabarap, critical proteins that
are destroyed during autophagosome fusion with lysosome. This
suggests that different signaling pathways may control autophago-
some formation during short (hours) or long (days) periods of in-
duced autophagy. The balance between inhibitors and activators
of autophagic machinery determines the amount of newly formed
vesicles in addition to their growth, delivery and fusion with lyso-
somes during catabolic conditions. In skeletal muscles, few
autophagy suppressors have been reported, the ﬁrst of which
was Runx1. In fact, denervation is able to induce autophagy in skel-
etal muscles, although at a slower rate than fasting [42,43]. This ef-
fect is mediated by Runx1, which is upregulated in denervated
muscles and is required to preserve muscle mass [44]. In fact,
Runx1 ablation results in excessive autophagy during denervation
which leads to severe atrophy [44]. The mechanisms of Runx1-
mediated autophagy suppression is unclear but recent evidence
shows that Runx1 can modulate FoxO3 action [45]. In hepatic cell
lines Runx1 interacts with FoxO3 promoting FoxO3 recruitment to
the Bim promoter [45]. It is of interest understanding whether
upregulation of Runx1 in denervated muscles negatively affects
FoxO3 recruitment to the promoters of autophagy genes and in
doing so reduces autophagy ﬂux.
Another negative regulator of autophagy in muscle cells is the
phosphatase Jumpy. Reduction of Jumpy protein by RNAi results
in the formation of autophagosomes in C2C12 myoblasts and an in-
creased rate of proteolysis observed both in normal and starvation
media [23]. Jumpy blocks autophagosome formation by reducing
the levels of PI3P and therefore counteracting the action of the
class III PI3 kinase, VPS34. However, the regulation of Jumpy in
normal and atrophic muscles is still unknown.
The most potent autophagy inhibitor in skeletal muscles is the
kinase Akt. Acute activation of Akt in adult mice or in muscle cell
cultures completely inhibits autophagosome formation and lyso-
somal-dependent protein degradation during fasting [10–12,46].
Mammalian TOR (mTOR) is a nutrient-sensitive kinase down-
stream of Akt that is important for cell growth. In fact muscle
hypertrophy requires mTOR since treatment with rapamyicin, anmTOR inhibitor, completely blocks muscle growth of adult or
regenerating myoﬁbers [47,48]. However, the role of mTOR in
autophagy regulation is much less important and therefore, mTOR,
at least in skeletal muscles, does not mediate the negative effect of
Akt on the autophagy pathway. Accurate biochemical studies have
determined that rapamycin-mediated mTOR inhibition only barely
(10%) increases protein breakdown in differentiated myotubes.
This response is much smaller than the 50% increase of protein
breakdown induced by Akt inhibition [12]. Importantly, in vivo
inhibition of mTOR by rapamycin and by RNAi is not sufﬁcient to
induce atrophy and autophagosome formation [10,12,49]. Further-
more, the deletion of mTOR gene speciﬁcally in skeletal muscles
leads to muscular dystrophy rather than atrophy [50]. However,
it is important to underline that mTOR deletion, similar to RAPTOR
and RICTOR deﬁcient muscles [51], causes a hyperactivation of Akt.
The hyperphosphorylation of Akt can blunt or mitigate the effects
of mTOR ablation on the autophagy system. However, previous
studies have conﬁrmed an mTOR-independent but VPS34-be-
clin1-dependent control of the autophagic system in myotubes
[52,53]. Moreover, deletion of S6K1, a downstream target of mTOR,
and of S6K2 does not affect the autophagic ﬂux in cultured myotu-
bes [54]. Therefore, the inhibition of the IGF1-Akt pathway during
fasting must stimulate autophagy mainly via mTOR-independent
mechanisms.
The upregulation of several autophagy-related genes in atro-
phying muscles [7,10,12,42,43] suggests the contribution of one
or more transcription factors to autophagy regulation. We recently
identiﬁed FoxO3 as the critical factor for autophagy control in adult
muscles. Expression of FoxO3 is sufﬁcient and required to activate
lysosomal-dependent protein breakdown in cell culture and in
vivo. Moreover several autophagy genes including LC3, Gabarap,
Bnip3, VPS34, Atg12 are under FoxO3 regulation. Gain and loss of
function experiments identiﬁed Bnip3, a BH3-only protein, as a
central player downstream of FoxO [10,55]. Indeed, Bnip3 is regu-
lated by DAF-16, the homolog of FoxO, in Caenorhabditis elegans
[56] and overexpression of Bnip3 induces mitochondrial fragmen-
tation and autophagy in cardiomyocytes exposed to ischemia/
reperfusion conditions [57]. Overexpression of Bnip3 per se is able
to induce autophagy in skeletal muscle in vivo whereas Bnip3
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dependent regulation of autophagy seems to be a general mecha-
nism to sustain autophagy for long periods. In fact FoxO-dependent
transcriptional upregulation of several autophagy-related genes
have been described in Drosophila larval fat body [58], mammalian
cardiomyocytes [59,60], hepatocytes [61], colorectal cancer cells
[62] and during cellular senescence [63]. The contribution of each
FoxO member to autophagy regulation must be better analyzed by
loss of function approaches.
Recently, the p38 ab MAPK pathway was also described to reg-
ulate expression of autophagy-related genes independently of
FoxO3 during oxidative stress [64]. However, the speciﬁc transcrip-
tion factors downstream of p38MAPK that induce autophagy in
atrophying myotubes remains unclear. The interplay between
FoxO transcription factors and p38MAPK must be better clariﬁed
in the future since an opposing conclusion was reached in a recent
paper. In this case, p38 MAPK inhibition triggered autophagy-re-
lated gene expression via AMPK-FoxO3 axis in colorectal cancer
cells [62]. The picture of both positive and negative modulators
of the autophagy system in skeletal muscle is just at the beginning
(Fig. 2) and will need to be better deﬁned and completed in the
coming years.
5. Conclusions
The autophagy-lysosome system is emerging as a crucial sys-
tem that controls muscle mass during catabolic conditions. How-
ever, the autophagy system is also required for basal myoﬁber
homeostasis and its inhibition can lead to myoﬁber degeneration.
We therefore need a more precise understanding of the signaling
pathways that control the autophagy system and its interrelation
with the ubiquitin-proteasome pathway. Indentifying the muscle
proteins that are targeted to autophagy and uncovering the molec-
ular mechanisms that deliver them for lysosomal degradation are
additional important issues that need to be addressed in the com-
ing years.
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